Cargando…

Editorial: Unravelling the role of CB2r in neuropsychiatric diseases

Detalles Bibliográficos
Autor principal:	Onaivi, Emmanuel S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10067863/ https://www.ncbi.nlm.nih.gov/pubmed/37020728 http://dx.doi.org/10.3389/fpsyt.2023.1171959

Ejemplares similares

Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2022)

Cell-Type Specific Deletion of CB2 Cannabinoid Receptors in Dopamine Neurons Induced Hyperactivity Phenotype: Possible Relevance to Attention-Deficit Hyperactivity Disorder
por: Canseco-Alba, Ana, et al.
Publicado: (2022)

Editorial: The heterogeneity of neuropsychiatric disorders
por: Wu, Zhao-Min, et al.
Publicado: (2023)

Editorial: Neurological Soft Signs in Neuropsychiatric Conditions
por: Toro, Pablo, et al.
Publicado: (2019)

Editorial: Glutamate-Related Biomarkers for Neuropsychiatric Disorders
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Editorial: Temporal lobe dysfunction in neuropsychiatric disorder
por: Gao, Yujun, et al.
Publicado: (2022)

Editorial: Epidemiology and clinical researches on neuropsychiatric disorders in aging
por: Xie, Wuxiang, et al.
Publicado: (2023)

Editorial: Emotional Disturbance and Brain Imaging in Neuropsychiatric Disorders
por: Esposito, Roberto, et al.
Publicado: (2021)

Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS
por: Onaivi, E.S
Publicado: (2011)

Immunomodulatory Role of CB2 Receptors in Emotional and Cognitive Disorders
por: Morcuende, Alvaro, et al.
Publicado: (2022)

Low Basal CB2R in Dopamine Neurons and Microglia Influences Cannabinoid Tetrad Effects
por: Liu, Qing-Rong, et al.
Publicado: (2020)

Editorial: Unraveling Neuroprotective and Neurodegenerative Signals in Neurodegeneration
por: Vega, Irving E., et al.
Publicado: (2016)

Editorial: Neuroimaging insights into the link between sleep disturbances and neuropsychiatric disorders
por: von Deneen, Karen M., et al.
Publicado: (2023)

Editorial: Neurodevelopmental, neuropsychiatric and psychosocial correlates of joint hypermobility and related disorders
por: Guinchat, Vincent, et al.
Publicado: (2022)

CB(2) Cannabinoid Receptor As Potential Target against Alzheimer's Disease
por: Aso, Ester, et al.
Publicado: (2016)

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
por: Kibret, Berhanu Geresu, et al.
Publicado: (2022)

Editorial: The affective side of Alzheimer's disease (AD): neuropsychiatric symptoms as early sentinel of cognitive decline and pathogenetic factors in disease progression
por: Cutuli, Debora, et al.
Publicado: (2023)

Are CB2 Receptors a New Target for Schizophrenia Treatment?
por: Cortez, Isadora L., et al.
Publicado: (2020)

Cannabinoid CB2 Receptor Gene and Environmental Interaction in the Development of Psychiatric Disorders
por: Ishiguro, Hiroki, et al.
Publicado: (2018)

Neuropsychiatric Symptoms in Parkinson’s Disease: Beyond Complications
por: Kehagia, Angie A.
Publicado: (2016)

Brain CB(2) Receptors: Implications for Neuropsychiatric Disorders
por: Roche, Michelle, et al.
Publicado: (2010)

NMDA Receptor Activity in Neuropsychiatric Disorders
por: Lakhan, Shaheen E., et al.
Publicado: (2013)

Cannabinoid Regulation of Brain Reward Processing with an Emphasis on the Role of CB(1) Receptors: A Step Back into the Future
por: Panagis, George, et al.
Publicado: (2014)

Neuropsychiatric symptoms and altered sleep quality in cerebral small vessel disease
por: Li, Xi, et al.
Publicado: (2022)

Involvement of CB2 Receptors in the Neurobehavioral Effects of Catha Edulis (Vahl) Endl. (Khat) in Mice
por: Geresu, Berhanu, et al.
Publicado: (2019)

Editorial: Cognitive, Psychological, and Psychiatric Consequences of the Coronavirus (COVID-19) Pandemic in the Population of Older Persons With Cognitive Impairment, Dementia, and/or Neuropsychiatric Disorders
por: Palmer, Katie, et al.
Publicado: (2021)

New Challenges and Frontiers in the Research for Neuropsychiatric Disorders
por: Tropea, Daniela
Publicado: (2012)

Fragile X-Associated Neuropsychiatric Disorders (FXAND)
por: Hagerman, Randi J., et al.
Publicado: (2018)

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Sethi, Rickinder, et al.
Publicado: (2019)

Cannabinoid Type 2 (CB(2)) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson's Disease
por: Javed, Hayate, et al.
Publicado: (2016)

Case Report: PANDAS and Persistent Lyme Disease With Neuropsychiatric Symptoms: Treatment, Resolution, and Recovery
por: Cross, Amy, et al.
Publicado: (2021)

Multimodal Neuroimaging-Informed Clinical Applications in Neuropsychiatric Disorders
por: O’Halloran, Rafael, et al.
Publicado: (2016)

Long-Term Comorbid Neuropsychiatric Sequelae of Hypoxia at Birth
por: Mercogliano, Christina, et al.
Publicado: (2021)

Commentary: Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders
por: Westwell-Roper, Clara, et al.
Publicado: (2020)

Understanding Neuropsychiatric Diseases, Analyzing the Peptide Sharing between Infectious Agents and the Language-Associated NMDA 2A Protein
por: Lucchese, Guglielmo
Publicado: (2016)

Disturbed Amino Acid Metabolism in HIV: Association with Neuropsychiatric Symptoms
por: Gostner, Johanna M., et al.
Publicado: (2015)

The Oral-Microbiome-Brain Axis and Neuropsychiatric Disorders: An Anthropological Perspective
por: Bowland, Grace B., et al.
Publicado: (2022)

Prenatal Cannabinoid Exposure: Emerging Evidence of Physiological and Neuropsychiatric Abnormalities
por: Nashed, Mina G., et al.
Publicado: (2021)

SPECT findings on neuropsychiatric symptoms caused by nitrous oxide abuse
por: Wang, Li, et al.
Publicado: (2022)

Neuropsychiatric Symptoms in Mild Cognitive Impairment and Dementia Due to AD: Relation With Disease Stage and Cognitive Deficits
por: Wiels, Wietse A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9v1befi5c71bi06m89j34llnpm